Purpose: Oral supplementation with omega 3 (v-3) and /or 6 (v-6) fatty acids (FAs) has been reported to alleviate the signs and symptoms of dry eye disease and to improve the expressibility and quality of meibum, in patients with meibomian gland dysfunction. We tested our hypothesis that these FA effects may reflect a direct FA action on human meibomian gland epithelial cells.
T hroughout the world, countless individuals suffer from tear film dysfunctions, which are collectively diagnosed as dry eye disease (DED).
1,2 Indeed, DED afflicts more than 40 million in the United States alone and is one of the most frequent reasons for patient visits to eye care practitioners. 1 DED is characterized by a vicious cycle of tear film hyperosmolarity and instability and corneal stress, leading to increased friction, inflammation, ocular surface damage, and decreased visual acuity. 1, 2 The major cause of DED is obstructive meibomian gland dysfunction (MGD). 3, 4 MGD, in turn, is caused by hyperkeratinization of the ductal epithelium and an increased viscosity (ie reduced quality) of meibum, resulting in lipid insufficiency and a heightened evaporation and instability of the tear film. 3, 5 There is no global cure for either DED or MGD. However, investigators have recently reported that oral supplementation with omega 3 (v-3) and/or 6 (v-6) fatty acids (FAs) may alleviate the signs and symptoms of DED and improve the expressibility and quality of meibum, in patients with MGD. [6] [7] [8] [9] [10] [11] These findings have led to the use of v-FAs as a DED and/or MGD treatment. [12] [13] [14] Yet the mechanism(s) underlying these v-FA effects are not completely understood. 15 We hypothesize that these v-FA actions reflect, at least in part, a direct influence on the quality and quantity of lipids produced by human meibomian gland epithelial cells. The purpose of this study was to test our hypothesis.
MATERIAL AND METHODS

Cell Cultures
Immortalized human meibomian gland epithelial cells (IHMGECs) were cultured in the presence or absence of 10% fetal bovine serum, according to published protocols. [16] [17] [18] After reaching 80%-90% confluence (;5 · 10 6 per well), cells were exposed to ethanol vehicle, linolenic acid (v-3, 10 25 M; Santa Cruz Biotechnology, Dallas, TX), linoleic acid (v-6, 10 25 M; Sigma-Aldrich, St Louis, MO), or linolenic and linoleic acids together (0.5 · 10 25 + 0.5 · 10 25 M) for 5-7 days. Azithromycin (10 mg/mL, AZM; Santa Cruz Biotechnology) was used as a positive control in all experiments because this antibiotic has well-defined effects on both the proliferation and differentiation of IHMGECs. [19] [20] [21] [22] After treatment, cells were processed for enumerative, histological, and biochemical procedures.
Cell Analyses
Cells were counted with a hemocytometer. Total cellular neutral lipid and lysosome accumulation were evaluated by staining cells with LipidTOX green neutral lipid stain (Invitrogen, Grand Island, NY) and LysoTracker Red DND-99 (Invitrogen), a fluorescent probe designed for labeling acidic organelles (eg lysosomes), as previously reported. [19] [20] [21] [22] The cellular content of free and esterified cholesterol, triglycerides, phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositol was determined by high-performance thin-layer chromatography (HPTLC, Silica Gel 60; Merck, Darmstadt, Germany) as described. 20, 22 The cellular lysate levels of Lamp-1 and LC3 proteins, which are biomarkers for lysosomes and autophagosomes, 23, 24 were assessed by Western blots. Methods involved use of primary antibodies specific for Lamp-1 (1:350, H4A3; Developmental Studies Hybridoma Bank, Iowa City, IA), LC3 (1:1,000; Cell Signaling Technology, Danvers, MA), or b-actin (1:10,000; Cell Signaling Technology), followed by development with horseradish peroxidase-conjugated secondary antibodies (1:5000; Sigma-Aldrich).
Each experiment was performed in duplicate or triplicate under the same conditions and repeated at least 3 times. Staining intensities were quantified with ImageJ (http:// rsbweb.nih.gov/ij/index.html). Data were analyzed by analysis of variance and Newman-Keuls multiple comparisons tests using Prism 5 software (GraphPad Software, Inc, La Jolla, CA).
RESULTS
Influence of v-3 and/or v-6 on Lipid Expression in IHMGECs
To determine whether v-3 and/or v-6 influence the quantity and quality of lipids in IHMGECs, we treated cells with these FAs or vehicle for 7 days and then processed the samples for histological and biochemical procedures. Our findings demonstrate that v-3, v-6, and their combination stimulate the accumulation of small neutral lipid-containing vesicles in IHMGECs (Fig. 1 ). This vesicular effect was associated with a significant 2.4-to 3.7-fold increase in the cellular content of triglycerides after v-3 and v-6 treatment, respectively. The combination of both FAs together also enhanced triglyceride levels. Of particular interest, culture of IHMGECs with v-3 and AZM led to a significantly greater amount of total neutral lipids, relative to that found with AZM alone (Fig. 1) . IHMGEC exposure to the FAs did not alter the expression of free or esterified cholesterol, or phospholipids (data not shown).
Effect of v-3 and/or v-6 on the Accumulation of Acidic Organelles in IHMGECs
To evaluate whether v-3 and/or v-6 promote the accumulation of acidic organelles in IHMGECs, we cultured cells with FAs or vehicle, with or without AZM, for up to FIGURE 1. Effects of v-3 and/or v-6 on the quantity and quality of lipids in IHMGECs. Cells were treated with vehicle, 10 25 M v-3, 10 25 M v-6, v-3 + v-6 (each 0.5 · 10 25 ) or FAs combined with 10 mg/mL AZM for 7 days. A, Cells were stained with LipidTOX, and the green color indicates neutral lipids. The images were obtained with a fluorescent microscope. B, The fluorescence intensity of Lipid TOX staining was measured by using ImageJ. ***P , 0.001 and ****P , 0.0001 versus control. † †P , 0.01 and † † †P , 0.001 versus AZM. The experiments were repeated 3 times, and the results from a single experiment are shown. C, The lipid extractions were analyzed by HPTLC, and the band intensities were measured by using ImageJ; control band intensity was set to 1, and data (mean 6 SE) are reported as fold-change compared with control values. The results displayed are from 5 separate experiments.
7 days before analyzing samples with microscopy and Western blots. As shown in Figure 2 , our results demonstrate that these FAs, whether alone or together, had no effect on the relative number of these organelles. However, these FAs did reduce the stimulatory effect of AZM on the organelle accumulation. This antagonistic influence of v-3 and/or v-6 did not extend to the levels of Lamp-1 or LC3. The FAs had no impact on these protein amounts, regardless of whether IHMGECs were cultured with v-3 and/or v-6 in the presence or absence of AZM.
Influence of v-3 and/or v-6 on the Proliferation of IHMGECs
To assess whether v-3 and/or v-6 influence the proliferation of IHMGECs, we cultured cells with these FAs or vehicle in serum-free or serum-containing media for 5 days. We also compared their effect, if any, with that of AZM, which is known to reduce the proliferation of IHMGECs in serum-free conditions. 21 Our findings demonstrate that v-3 and v-6, alone or together, prevented, whereas AZM decreased, the proliferation of IHMGECs in serum-free media FIGURE 2. Influence of v-3 and/or v-6 on the accumulation of acidic organelles in IHMGECs. Cells were cultured with vehicle, 10 25 M v-3, 10 25 M v-6, v-3 + v-6 (each 0.5 · 10 25 ), or FAs combined with 10 mg/mL AZM for 7 days in (A) and (B), and for 5 days in (C), (D), and (E). A, Cell samples in duplicate were exposed to LysoTracker, which stains acidic organelles in red color. Images were obtained with a fluorescent microscope. B, The fluorescence intensities were measured using ImageJ. ****P , 0.0001 versus control. * †,0.05, ** †,0.01 versus AZM. The staining was repeated 3 times, and the results shown are from a single experiment. C, Cell lysates were evaluated on Western blots for Lamp-1 and LC3 in triplicate. D, The samples containing AZM showed a significant increase of Lamp-1 level compared with control. *P , 0.05. E, There was no significant difference between the effects of v-3 or v-6 combined with AZM or AZM alone. The remaining samples displayed weak signals for LC3 expression. (Fig. 3) . In contrast, these treatments had no impact on IHMGEC proliferation in serum-containing media.
DISCUSSION
Our findings support our hypothesis and demonstrate that v-3 and v-6 can act directly on IHMGECs to influence the quality and quantity of intracellular lipids. Our research shows that v-3 and v-6 stimulate the accumulation of small neutral lipid-containing vesicles, but not lysosomes, in IHMGECs. This vesicular effect was associated with an increase in the cellular content of triglycerides. Cellular exposure to v-3 also enhanced the impact of AZM on neutral lipid accumulation. In contrast, the v-FAs prevented IHMGEC proliferation in serum-free media.
Our discovery that v-FAs act directly on IHMGECs to influence lipid expression is not surprising. The meibomian gland is a large sebaceous gland, and researchers have reported that v-6 stimulates the differentiation of, and lipogenesis in, sebaceous gland epithelial cells (sebocytes). [25] [26] [27] Further, we have previously found that v-3 intake is associated with a significant change in the lipid profile of human meibum. 28 It is possible that these types of responses may contribute to the qualitative improvement of human meibomian gland secretions, and the reduction in meibomian gland obstruction, in MGD patients after oral v-FA intake. 8 Of particular interest was our finding that v-FAs promote the IHMGEC accumulation of small neutral lipidcontaining vesicles, which seem to be enriched in triglycerides. These vesicles may well be lipid droplets, which are the main storage organelles for triglycerides in eukaryotic cells and play roles in membrane biosynthesis, lipid homeostasis, and defense against lipotoxicity. 29 In support of this possibility, lipid droplets are known to be present in sebocytes, and their number is increased by v-FA exposure. 30 This sebaceous response, in turn, is paralleled by a heightened mRNA expression of perilipins (also called lipid storage protein 5) in general, and of perilipin 2 protein [also called adipose differentiation-related protein (ADRP)] in particular. 30 Perilipins are proteins that coat lipid droplets and regulate their storage and use of lipids. 31 We have found lipid storage protein 5 mRNA in human meibomian glands (Sullivan et al, unpublished data) and ADRP mRNA in mouse meibomian glands. 32 Moreover, investigators have identified ADRP in lipid droplets of rat meibomian gland epithelial cells. 33, 34 In effect, v-FAs may modulate lipid droplet dynamics in human meibomian gland epithelial cells, although additional research is required to demonstrate this action.
The accumulation of lipid droplets and the presence of ADRP have been linked to differentiation, and not proliferation, of rat meibomian gland epithelial cells. 33, 34 Similarly, we have discovered that the upregulation of genes promoting lipid biosynthesis and ADRP appearance is associated with increased differentiative, and decreased proliferative, cellular processes in human and mouse meibomian glands. 32, 35 These findings suggest that v-FA treatment enhances the differentiation and not the proliferation of IHMGECs. Consistent with this suggestion is our observation that the v-FAs prevented the proliferation of IHMGECs in serum-free (ie, proliferating) media. Such prevention was not found in serum-containing (ie, differentiating) media, given that this culture condition does not promote IHMGEC proliferation. 17 The ability of v-FAs to suppress cell growth has also been found in pancreatic and colorectal cells. 36, 37 We found that v-3 and v-6, alone or together, significantly increased the triglyceride content in IHMGECs. This effect might explain how the v-FAs enhanced AZM's impact on neutral lipid accumulation, given that AZM typically elevates the IHMGEC levels of cholesterol, cholesterol ester, and phospholipids, but reduces those of triglycerides. 19, 21, 22 The v-FAs may have countered the AZM-induced loss of triglycerides, leading to increased LipidTOX staining of the IHMGECs. In contrast, the v-FAs seemed to decrease the AZM-induced generation of lysosomes, as identified by LysoTracker. LysoTracker is an acidotropic probe that selectively accumulates in acidic compartments. This attenuated lysosome finding is likely a technical artifact. Both v-3 and v-6 cause pH changes in cellular organelles, which may lead to diminished LysoTracker staining. 38 Given that the protein levels of Lamp-1 and LC3, which are biomarkers for lysosomes and autophagosomes, 23, 24 were not reduced by v-FA exposure, we conclude that no alterations occurred in lysosome numbers. This inconsistency between the staining and immunoblot results suggests that LysoTracker staining may not be the best way to monitor lysosomes in experiments involving v-FAs.
Overall, our study demonstrates that v-3 and v-6 directly influence the quality and quantity of lipids and lipid-containing vesicles in IHMGECs and seem to promote
